Your SlideShare is downloading. ×
Dermatology Partnering Terms and Agreements
The Dermatology Partnering Terms and Agreements report provides a detailed und...
benefits: In-depth understanding of dermatology deal trends since 2007 Access dermatology deal headline,
upfront, mileston...
chapter 4 – Bigpharma Dermatology Deals
4.1. Introduction
4.2. How To Use Bigpharma Partnering Deals
4.3. Bigpharma ...
co-development
collaborative R&d
co-market
contract Service
co-promotion
development
distribution
equity Purchase
joint Ve...
oligonucleotide
orphan Drug
peptides
processes
recombinant Dna
regenerative Medicine
research Services
research Supplies
s...
asset Purchase
assignment
bigpharma Outlicensing
co-development
collaborative R&d
co-market
contract Service
co-promotion
...
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Indus...
Upcoming SlideShare
Loading in...5
×

Researchmoz | Dermatology Partnering Terms And Agreements

68

Published on

http://www.researchmoz.us/dermatology-partnering-terms-and-agreements-report.html

Dermatology Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals. The majority of deals are discovery, preclinical or development stage whereby the licensee obtains a right or an option right tlicense the licensors dermatology technology. These deals tend tbe multicomponent, starting with collaborative R&D, and commercialization of outcomes.

This report provides details of the latest dermatology deals and contracts announced in the healthcare sectors.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight intthe negotiation process in terms of what you can expect tachieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases dnot.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
68
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "Researchmoz | Dermatology Partnering Terms And Agreements"

  1. 1. Dermatology Partnering Terms and Agreements The Dermatology Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter dermatology partnering deals. The majority of deals are discovery, preclinical or development stage whereby the licensee obtains a right or an option right tlicense the licensors dermatology technology. These deals tend tbe multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest dermatology deals and contracts announced in the healthcare sectors. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight intthe negotiation process in terms of what you can expect tachieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases dnot. The report includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. The initial chapters of this report provide an orientation of dermatology dealmaking and business activities. Chapter 1 provides an introduction tthe report. Chapter 2 provides an overview of the trends in dermatology dealmaking since 2007 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development. Chapter 3 provides a review of the leading dermatology deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access tthe contract. Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of dermatology deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink tan online version of the actual contract document, providing easy access teach contract document on demand. Chapter 5 provides comprehensive access tall dermatology deals since 2007 where a deal contract is available, providing the user with direct access tcontracts as filed with the SEC regulatory authorities. Each deal title links via Weblink tan online version of the deal record contract document, providing easy access teach contract document on demand. Chapter 6 provides a comprehensive directory of all dermatology partnering deals signed and announced since 2007. The chapter is organized by specific dermatology therapy focus. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand. In addition, a comprehensive appendix is provided with each report of all dermatology partnering deals signed and announced since 2007. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand. The report alsincludes numerous tables and figures that illustrate the trends and activities in dermatology partnering and dealmaking since 2007. In conclusion, this report provides everything a prospective dealmaker needs tknow about partnering in the research, development and commercialization of dermatology technologies and products. Key benefits Dermatology Partnering Terms and Agreementsprovides the reader with the following key Dermatology Partnering Terms and Agreements
  2. 2. benefits: In-depth understanding of dermatology deal trends since 2007 Access dermatology deal headline, upfront, milestone and royalty data Research hundreds of actual contracts between dermatology partner companies Comprehensive access tover 1500 links tactual dermatology deals entered intby the world’s biopharma companies Indepth review of dermatology deals entered intby the leading fifty bigpharma companies Benchmark the key deal terms companies have agreed in previous deals Identify key terms under which companies partner dermatology opportunities Uncover companies actively partnering dermatology opportunities Report scope Dermatology Partnering Terms and Agreements is intended tprovide the reader with an in-depth understanding and access tdermatology trends and structure of deals entered intby leading companies worldwide. Dermatology Partnering Terms and Agreements includes: Trends in dermatology dealmaking in the biopharma industry since 2007 Analysis of dermatology deal structure Access theadline, upfront, milestone and royalty data Access thundreds of dermatology deal contract documents Comprehensive access tover 1500 dermatology deal records The leading dermatology deals by value since 2007 Most active dermatology dealmakers since 2007 In Dermatology Partnering Terms and Agreements, available deals and contracts are listed by: Headline value Upfront payment value Royalty rate value Stage of development at signing Deal component type Technology type Specific therapy indication table Of Contents executive Summary chapter 1 – Introduction chapter 2 – Trends In Dermatology Dealmaking 2.1. Introduction 2.2. Dermatology Partnering Over The Years 2.3. Bigpharma Dermatology Dealmaking Activity 2.4. Bigpharma Not Active In Dermatology 2.5. Dermatology Partnering By Deal Type 2.6. Dermatology Partnering By Industry Sector 2.7. Dermatology Partnering By Stage Of Development 2.8. Dermatology Partnering By Technology Type 2.9. Dermatology Partnering By Dermatology Indication 2.10. Average Deal Terms For Dermatology 2.10.1 Dermatology Headline Values 2.10.2 Dermatology Upfront Payments 2.10.3 Dermatology Milestone Payments 2.10.4 Dermatology Royalty Rates chapter 3 – Leading Dermatology Deals 3.1. Introduction 3.2. Top Dermatology Deals By Value 3.3. Top Dermatology Deals Involving Bigpharma Dermatology Partnering Terms and Agreements
  3. 3. chapter 4 – Bigpharma Dermatology Deals 4.1. Introduction 4.2. How To Use Bigpharma Partnering Deals 4.3. Bigpharma Dermatology Partnering Company Profiles abbott actavis actelion allergan amgen astellas astrazeneca baxter International bayer bristol-myers squibb C elgene eli Lilly endo Pharmaceuticals forest Laboratories galderma glaxosmithkline hospira johnson & Johnson merck & Co merck Kgaa mitsubishi Tanabe novartis pfizer roche sanofi shionogi shire teva warner Chilcott watson chapter 5 – Dermatology Partnering Contracts Directory 5.1. Introduction 5.2. By Deal Type asset Purchase assignment bigpharma Outlicensing Dermatology Partnering Terms and Agreements
  4. 4. co-development collaborative R&d co-market contract Service co-promotion development distribution equity Purchase joint Venture licensing litigation loan manufacturing marketing option promotion research settlement sub-license supply termination 5.3. By Stage Of Development discovery formulation marketed phase I phase Ii phase Iii preclinical 5.4. By Technology Type antibodies assays biologicalcompounds biomaterials clinical Testing devices diagnostics dna Probes drug Delivery enabling Technology equipment genomics natural Product Dermatology Partnering Terms and Agreements
  5. 5. oligonucleotide orphan Drug peptides processes recombinant Dna regenerative Medicine research Services research Supplies screening small Molecules stem Cells chapter 6 – Dermatology Dealmaking By Indication 6.1. Introduction 6.2. Deals By Therapeutic Indication dermatology acne actinickeratosis angioedema burns cellulitis cosmetics dermatitis diabetic Foot Ulcer eczema Hair Disorders impetigo itching nail Disorders psoriasis Rosacea sun Damage rash Scar venous Ulcer wound Healing wrinkles chapter 7 – Partnering Resource Center 7.1. Online Partnering 7.2. Partnering Events 7.3. Further Reading On Dealmaking appendices appendix 1 – Directory Of Dermatology Deals By Company A-z 2007-2012 appendix 2 – Directory Of Dermatology Deals By Deal Type 2007-2012 Dermatology Partnering Terms and Agreements
  6. 6. asset Purchase assignment bigpharma Outlicensing co-development collaborative R&d co-market contract Service co-promotion crada cross-licensing development distribution equity Purchase evaluation grant joint Venture licensing litigation loan manufacturing manufacturing - Oem marketing material Transfer option promotion research royalty Financing settlement spin Out sub-license supply technology Transfer termination warranty appendix 3 - Directory Of Dermatology Deals By Stage Of Development 2007-2012 appendix 4 – Directory Of Dermatology Deals By Technology Type 2007 appendix 5 – Deal Type Definitions about Wildwood Ventures current Partnering current Agreements recent Titles From Currentpartnering order Form – Reports Dermatology Partnering Terms and Agreements
  7. 7. ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Dermatology Partnering Terms and Agreements

×